about
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyAn autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014Transmission potential of chikungunya virus and control measures: the case of Italy.School closures during the 2009 influenza pandemic: national and local experiencesI-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in EuropeSurfing the web during pandemic flu: availability of World Health Organization recommendations on preventionWest Nile virus surveillance in Europe: moving towards an integrated animal-human-vector approachBehavioural responses to influenza pandemics: what do we know?Age-prioritized use of antivirals during an influenza pandemic.Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility.Scenarios of diffusion and control of an influenza pandemic in Italy.Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenariosA/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.Epidemic patch models applied to pandemic influenza: contact matrix, stochasticity, robustness of predictions.Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.Epidemiology and transmission dynamics of the 1918-19 pandemic influenza in Florence, Italy.Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.Seasonal and pandemic influenza vaccine: recommendations to families of at-risk children during the 2009-10 season.An infectious disease model on empirical networks of human contact: bridging the gap between dynamic network data and contact matricesEpidemiological and virological investigation of a Norovirus outbreak in a resort in Puglia, Italy.Close encounters in a pediatric ward: measuring face-to-face proximity and mixing patterns with wearable sensors.Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013An early warning system based on syndromic surveillance to detect potential health emergencies among migrants: results of a two-year experience in ItalyPerspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Vector borne infections in Italy: results of the integrated surveillance system for West Nile disease in 2013Spatio-Temporal Identification of Areas Suitable for West Nile Disease in the Mediterranean Basin and Central Europe.Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013.The Anopheles gambiae salivary protein gSG6: an anopheline-specific protein with a blood-feeding roleIntegrated human surveillance systems of West Nile virus infections in Italy: the 2012 experience.West Nile Virus infections in children: a disease pediatricians should think about.MRSA nasal colonization in children: prevalence meta-analysis, review of risk factors and molecular genetics.Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.Cutaneous manifestations of Mycobacterium gordonae infection described for the first time in Italy: a case report.Estimated imported infections of Chikungunya and Dengue in Italy, 2008 to 2011.I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence.Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
P50
Q21144621-024CD08F-0369-4F8F-94A4-DACD14A3970DQ24574380-730B06C5-0B54-4B68-9437-57859DCBC445Q28656275-207C2E72-2EA2-4600-BA55-BCA94FCDFC10Q28660269-1511018E-682B-4DEC-979B-7FC0D9D450BCQ28742719-58F1FF41-BE96-48DF-9626-2B1632A1647EQ28748860-09D71106-E3CF-424D-9566-FCDF417C1E50Q30148658-96CA3282-D614-417A-A16F-B2848FC058EDQ30227378-6F24C333-FF8B-4009-9449-49DD23179E53Q30227718-4263F9A3-62FD-43DB-A113-9FB8E6A5E347Q30354383-DE036DF5-41D1-45A7-AB7E-795F85C5C1EFQ30367736-0A6E91BF-3303-4A6D-A0A8-1D45C6BAEC7DQ30368195-9AF246AB-14DD-4D30-9694-F68269739319Q30373182-48BC4D73-477C-4506-A6D2-BA7AADEDC358Q30376196-EA1859C0-03BF-4ECE-9698-4CED270F2B18Q30387150-4D8CDEF4-F2BF-41A3-AAC7-57C5EC866F33Q30390309-5F05B27B-410E-4F56-965D-0CAB5BD76EFAQ30403272-A263BEF2-3A5A-4BF5-8D3E-929CC1217F8AQ30404861-98369C35-4DAC-4DBB-AA89-DA174FBA9978Q30409739-4CF77374-3BF6-4F11-A3F8-8D0A81E45985Q30412752-162EA112-8981-4626-A176-CE4819D8EC24Q30619880-7355F8FB-A784-41A1-9271-F55C32462195Q33306158-12AF1662-B674-41DE-977E-F2BC15580169Q33840823-511E2344-8593-4BF7-A788-FE4B74A7270EQ33931458-4B4030B5-FDE2-4CCB-AF6A-EBCB18C7C48EQ34006763-C5047684-A5BD-45CD-A365-B92EDE13114DQ34086205-152B9DDE-8236-48AF-99E5-AF75D2D38A28Q34683751-7F06BDB4-E999-43CC-8DDE-34D405DE04FCQ35271021-2A85A577-DB63-42E0-8D65-3A87AE92E085Q35881937-8790028D-10F6-4276-B060-C084A034DDDFQ35931499-231C150C-943D-43AE-9FFA-EE027C1C3AF5Q37087458-6AF444AA-018C-4903-8D71-66CEB1679142Q37434935-2E0B44A9-640C-4131-826D-FB5D6F9D8E79Q37822649-054F2692-2154-487F-87E1-8BA25EFF1248Q38076018-09996FC0-D028-4971-89A4-B112EA610E8FQ38678530-A02702E7-FA61-4BDA-A7E0-A9B84E8AF154Q39216732-7E8FE252-4AB8-4F44-B90F-624269A45C60Q39293679-009EA218-5E0E-43DB-B244-904D2AA6A3C1Q39813822-D0DC7815-251D-4A1A-A345-007C0516F129Q39922467-EF6B6126-AC5C-46E6-BB1F-15BD8F6206A3Q39961932-BA8AE53E-F940-4CBB-A92E-5E60BEB20F95
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caterina Rizzo
@ast
Caterina Rizzo
@en
Caterina Rizzo
@es
Caterina Rizzo
@nl
Caterina Rizzo
@sl
type
label
Caterina Rizzo
@ast
Caterina Rizzo
@en
Caterina Rizzo
@es
Caterina Rizzo
@nl
Caterina Rizzo
@sl
prefLabel
Caterina Rizzo
@ast
Caterina Rizzo
@en
Caterina Rizzo
@es
Caterina Rizzo
@nl
Caterina Rizzo
@sl
P106
P21
P31
P496
0000-0002-5583-7508